A detailed history of Nichols & Pratt Advisers LLP transactions in Amgen Inc stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 4,144 shares of AMGN stock, worth $1.09 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,144
Previous 4,244 2.36%
Holding current value
$1.09 Million
Previous $1.33 Million 0.68%
% of portfolio
0.09%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$309.38 - $337.38 $30,938 - $33,738
-100 Reduced 2.36%
4,144 $1.34 Million
Q2 2024

Jul 25, 2024

SELL
$262.75 - $319.31 $39,412 - $47,896
-150 Reduced 3.41%
4,244 $1.33 Million
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $188,209 - $227,192
-700 Reduced 13.74%
4,394 $1.25 Million
Q3 2023

Nov 09, 2023

BUY
$218.65 - $271.46 $121,788 - $151,203
557 Added 12.28%
5,094 $1.37 Million
Q2 2023

Aug 02, 2023

SELL
$214.27 - $253.37 $8,142 - $9,628
-38 Reduced 0.83%
4,537 $1.01 Million
Q4 2022

Feb 03, 2023

BUY
$229.03 - $291.01 $137,418 - $174,606
600 Added 15.09%
4,575 $1.2 Million
Q3 2022

Nov 01, 2022

SELL
$224.46 - $253.15 $22,446 - $25,315
-100 Reduced 2.45%
3,975 $896,000
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $64,636 - $73,970
-325 Reduced 7.39%
4,075 $917,000
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $23,358 - $25,914
-100 Reduced 2.22%
4,400 $1.07 Million
Q1 2020

Apr 24, 2020

BUY
$182.24 - $241.7 $107,521 - $142,603
590 Added 15.09%
4,500 $913,000
Q4 2019

Feb 07, 2020

SELL
$189.21 - $243.2 $212,861 - $273,600
-1,125 Reduced 22.34%
3,910 $943,000
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $348 - $417
-2 Reduced 0.04%
5,035 $974,000
Q2 2019

Aug 05, 2019

SELL
$166.7 - $195.41 $8,335 - $9,770
-50 Reduced 0.98%
5,037 $928,000
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $196,133 - $219,141
1,162 Added 29.61%
5,087 $885,000
Q2 2017

Aug 08, 2017

BUY
N/A
3,925
3,925 $676,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nichols & Pratt Advisers LLP Portfolio

Follow Nichols & Pratt Advisers LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

News

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.